Stocks TelegraphStocks Telegraph
Stock Ideas

PSTX Financial Statements and Analysis

NASDAQ : PSTX

Poseida Therapeutics, Inc.

$9.50
00
Open: 4:00 PM
Not Actively Trading
61.72
BESG ScoreESG Rating

PSTX FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

PSTX Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue71.748M25.973M28.142M24.995M9.352M
cost of revenue01.349M1.38M4.176M1.444M
gross profit71.748M24.624M26.762M20.819M7.908M
gross profit ratio1.000.9480.9510.8330.846
research and development expenses41.914M44.198M41.541M42.046M37.482M
general and administrative expenses10.092M12.182M9.798M8.86M8.092M
selling and marketing expenses00000
selling general and administrative expenses10.092M12.182M9.798M8.86M8.092M
other expenses02.644M2.556M-12.024M6.787M
operating expenses52.006M56.38M51.339M50.906M45.574M
cost and expenses52.006M57.729M52.719M55.082M45.574M
interest income000-4.169M0
interest expense2.295M2.259M2.253M-10.604M-2.236M
depreciation and amortization1.319M1.349M1.38M-5.549M1.444M
ebitda23.892M-27.763M-20.641M-46.183M-36.222M
ebitda ratio0.333-1.171-0.824-1.848-3.873
operating income19.742M-31.756M-24.577M-25.911M-36.222M
operating income ratio0.275-1.223-0.873-1.037-3.873
total other income expenses net536.00K385.00K303.00K562.00K4.551M
income before tax20.278M-31.371M-24.274M-25.349M-31.671M
income before tax ratio0.283-1.208-0.863-1.014-3.387
income tax expense43.00K01.337M-6.04M-107.00K
net income20.235M-31.371M-24.274M-23.99M-31.778M
net income ratio0.282-1.208-0.863-0.96-3.398
eps0.21-0.32-0.25-0.27-0.35
eps diluted0.21-0.32-0.25-0.27-0.35
weighted average shs out97.16M96.965M96.02M90.185M91.898M
weighted average shs out dil98.22M96.965M96.02M90.185M91.898M
Graph

PSTX Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents49.34M30.545M53.297M44.472M25.503M
short term investments181.512M207.267M145.349M167.73M213.334M
cash and short term investments230.852M237.812M198.646M212.202M238.837M
net receivables14.749M12.427M12.027M9.01M8.672M
inventory00000
other current assets5.103M4.097M6.059M5.263M5.155M
total current assets250.704M254.336M216.732M226.475M252.664M
property plant equipment net36.42M37.721M39.219M40.781M42.953M
goodwill4.228M4.228M4.228M4.228M4.228M
intangible assets1.32M1.32M1.32M1.32M1.32M
goodwill and intangible assets5.548M5.548M5.548M5.548M5.548M
long term investments00000
tax assets00000
other non current assets905.00K1.081M1.081M1.081M1.087M
total non current assets42.873M44.35M45.848M47.41M49.588M
other assets01.00000
total assets293.577M298.686M262.58M273.885M302.252M
account payables5.197M2.99M2.704M3.267M2.542M
short term debt6.085M12.078M5.995M5.951M5.906M
tax payables00000
deferred revenue37.273M63.289M49.77M31.008M44.81M
other current liabilities29.714M24.077M26.294M31.092M23.715M
total current liabilities78.269M102.434M84.763M71.318M76.973M
long term debt76.642M77.614M78.566M79.472M80.354M
deferred revenue non current054.924M11.903M16.78M18.787M
deferred tax liabilities non current018.818M19.875M00
other non current liabilities51.455M2.897M2.754M2.614M2.478M
total non current liabilities128.097M135.435M93.223M98.866M101.619M
other liabilities001.0000
capital lease obligations23.819M18.818M19.875M26.833M27.769M
total liabilities206.366M237.869M177.986M170.184M178.592M
preferred stock00000
common stock10.00K10.00K10.00K10.00K10.00K
retained earnings-629.701M-649.936M-618.565M-594.291M-568.942M
accumulated other comprehensive income loss376.00K-82.00K-47.00K126.00K-200.00K
other total stockholders equity716.526M710.825M703.196M697.856M692.792M
total stockholders equity87.211M60.817M84.594M103.701M123.66M
total equity87.211M60.817M84.594M103.701M123.66M
total liabilities and stockholders equity293.577M298.686M262.58M273.885M302.252M
minority interest00000
total investments181.512M207.267M145.349M167.73M213.334M
total debt82.727M83.653M84.561M85.423M86.26M
net debt33.387M53.108M31.264M40.951M60.757M
Graph

PSTX Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax0003.989M-3.992M
stock based compensation4.959M7.629M5.383M5.063M5.117M
change in working capital-66.206M62.203M4.003M-22.043M38.857M
accounts receivables-2.323M-400.00K-3.016M-338.00K3.233M
inventory000-4.492M287.00K
accounts payables2.207M286.00K-563.00K736.00K433.00K
other working capital-69.899M62.317M7.582M-17.949M34.904M
other non cash items30.099M9.081M10.095M8.158M-1.76M
net cash provided by operating activities-9.594M38.45M-15.135M-28.744M7.888M
investments in property plant and equipment-645.001K-1.019M-130.00K-309.00K-789.00K
acquisitions net00040.626M0
purchases of investments-31.708M-102.683M-53.367M-21.978M-106.448M
sales maturities of investments60.00M42.50M77.50M70.00M60.00M
other investing activites1.00-60.183M24.133M-40.626M0
net cash used for investing activites27.647M-61.202M24.003M47.713M-47.237M
debt repayment00000
common stock issued-549.00K0549.00K-14.069M14.417M
common stock repurchased592.00K0-592.00K494.00K0
dividends paid00000
other financing activites699.00K0-592.00K13.575M524.00K
net cash used provided by financing activities742.00K0-43.00K94.817M14.941M
effect of forex changes on cash000-94.817M94.817M
net change in cash18.795M-22.752M8.825M18.969M-24.408M
cash at end of period49.34M30.545M53.297M44.472M25.503M
cash at beginning of period30.545M53.297M44.472M25.503M49.911M
operating cashflow-9.594M38.45M-15.135M-28.744M7.888M
capital expenditure-645.001K-1.019M-130.00K-309.00K-789.00K
free cash flow-10.239M37.431M-15.265M-29.053M7.099M
Graph

Frequently Asked Questions

How did Poseida Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, PSTX generated $71.75M in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Poseida Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Poseida Therapeutics, Inc. reported a $71.75M Gross Profit for the quarter ended Sep 30, 2024.

Have PSTX's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. PSTX incurred $52.01M worth of Operating Expenses, while it generated $19.74M worth of Operating Income.

How much Net Income has PSTX posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Poseida Therapeutics, Inc., the company generated $20.24M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Poseida Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Poseida Therapeutics, Inc. as of the end of the last quarter was $49.34M.

What are PSTX's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, PSTX had Total Net Receivables of $14.75M.

In terms of Total Assets and Current Assets, where did Poseida Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of PSTX were $250.70M, while the Total Assets stand at $293.58M.

As of the last quarter, how much Total Debt did Poseida Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of PSTX's debt was $82.73M at the end of the last quarter.

What were PSTX's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, PSTX reported total liabilities of $206.37M.

How much did PSTX's Working Capital change over the last quarter?

Working Capital Change for PSTX was -$66.21M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

PSTX generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. PSTX generated -$9.59M of Cash from Operating Activities during its recently reported quarter.

What was PSTX's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. PSTX reported a $18.80M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph